Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint. [electronic resource]
Producer: 20170214Description: 18495-507 p. digitalISSN:- 1949-2553
- Adenocarcinoma -- drug therapy
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cohort Studies
- DNA Replication
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Molecular Targeted Therapy
- Pancreatic Neoplasms -- drug therapy
- Piperidones -- pharmacology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyrroles -- pharmacology
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.